Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 9 Fallopian Tube Neoplasms 8 Breast Neoplasms 6 Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Recurrence 3 Prostatic Neoplasms 3 Endometrial Neoplasms 3 Small Cell Lung Carcinoma 2 Metastatic Castration Resistant Prostate Cancer 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor, Unspecified, Adult 1 Solid Tumor 1 Prostate Cancer Metastatic 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1 Lung Neoplasms 1 Genital Neoplasms, Male 1 Genital Neoplasms, Female 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1 Advanced Gastric Cancer 1 Adenocarcinoma, Clear Cell 1 Adenocarcinoma of Lung 1

Interventions

Prednisone 5 enzalutamide 4 cabazitaxel 4 Docetaxel 3 XRP6258 2 Abiraterone Acetate 2 sipuleucel-T 1 rucaparib 1 olaparib 1 apalutamide 1 Zuclomiphene 1 Standard of Care 1 Prednisolone 1 Lenograstim 1 LY3023414 1 Injections 1 Hematologic Tests 1 Granulocyte Colony-Stimulating Factor 1 Abituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostate Cancer Metastatic × rucaparib × Clear all

NCT03413995 2024-10-16

TRIUMPH

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

12 enrolled 11 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡